Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital.
Maurílio de Souza CazarimJoão Paulo Vilela RodriguesPriscila Santos CalciniThomas R EinarsonLeonardo Régis Leira PereiraPublished in: Revista de saude publica (2020)
The CP service was not directly cost-benefit at the hospital perspective, but it presented savings for forecast cost related to the occurrence of preventable morbidities, measuring a good cost-benefit for the PHS.